Please use this identifier to cite or link to this item:
Volltext verfügbar? / Dokumentlieferung
doi:10.22028/D291-43988
Title: | Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis |
Author(s): | Vukadinović, Davor Lauder, Lucas Kandzari, David E. Bhatt, Deepak L. Kirtane, Ajay J. Edelman, Elazer R. Schmieder, Roland E. Azizi, Michel Böhm, Michael Mahfoud, Felix |
Language: | English |
Title: | Circulation |
Volume: | 150 |
Issue: | 20 |
Pages: | 1599-1611 |
Publisher/Platform: | Wolters Kluwer |
Year of Publication: | 2024 |
Free key words: | arterial hypertension meta-analysis renal denervation |
DDC notations: | 610 Medicine and health |
Publikation type: | Journal Article |
Abstract: | BACKGROUND: Several sham-controlled trials have investigated the efficacy and safety of catheter-based renal denervation (RDN) with mixed outcomes. We aimed to perform a comprehensive meta-analysis of all randomized, sham-controlled trials investigating RDN with first- and second-generation devices in hypertension. METHODS: We searched MEDLINE and the Cochrane Library for eligible trials. Outcomes included both efficacy (24-hour and office systolic [SBP] and diastolic blood pressure [DBP]) and safety (all-cause death, vascular complication, renal artery stenosis >70%, hypertensive crisis) of RDN. We performed a study-level, pairwise, random-effects meta-analysis of the summary data. RESULTS: Ten trials comprising 2478 patients with hypertension while being either off or on treatment were included. Compared with sham, RDN reduced 24-hour and office systolic blood pressure by 4.4 mmHg (95% CI, 2.7 to 6.1; P<0.00001) and 6.6 mmHg (95% CI, 3.6 to 9.7; P<0.0001), respectively. The 24-hour and office diastolic blood pressure paralleled these findings (–2.6 mmHg [95% CI, –3.6 to –1.5]; P<0.00001; –3.5 mmHg [95% CI, –5.4 to –1.6]; P=0.0003). There was no difference in 24-hour and office systolic blood pressure reduction between trials with and without concomitant antihypertensive medication (P for interaction, 0.62 and 0.73, respectively). There was no relevant difference in vascular complications (odds ratio, 1.69 [95% CI, 0.57 to 5.0]; P=0.34), renal artery stenosis (odds ratio, 1.50 [95% CI, 0.06 to 36.97]; P=0.80), hypertensive crisis (odds ratio, 0.65 [95% CI, 0.30 to 1.38]; P=0.26), and all-cause death (odds ratio, 1.76 [95% CI, 0.34 to 9.20]; P=0.50) between RDN and sham groups. Change of renal function based on estimated glomerular filtration rate was comparable between groups (P for interaction, 0.84). There was significant heterogeneity between trials. CONCLUSIONS: RDN safely reduces ambulatory and office systolic blood pressure/diastolic blood pressure versus a sham procedure in the presence and absence of antihypertensive medications. |
DOI of the first publication: | 10.1161/CIRCULATIONAHA.124.069709 |
URL of the first publication: | https://doi.org/10.1161/CIRCULATIONAHA.124.069709 |
Link to this record: | urn:nbn:de:bsz:291--ds-439889 hdl:20.500.11880/39360 http://dx.doi.org/10.22028/D291-43988 |
ISSN: | 1524-4539 0009-7322 |
Date of registration: | 13-Jan-2025 |
Description of the related object: | Supplemental Material |
Related object: | https://www.ahajournals.org/doi/suppl/10.1161/CIRCULATIONAHA.124.069709/suppl_file/circ_circulationaha-2024-069709_supp1.pdf |
Faculty: | M - Medizinische Fakultät |
Department: | M - Innere Medizin |
Professorship: | M - Prof. Dr. Michael Böhm |
Collections: | SciDok - Der Wissenschaftsserver der Universität des Saarlandes |
Files for this record:
There are no files associated with this item.
Items in SciDok are protected by copyright, with all rights reserved, unless otherwise indicated.